GlassScriptPhysician profile
Benjamin Joseph Lundeen
NPI 1295009041
$3,160.09
in general payments reported to CMS, 2019-2025
17 companies · $991 in 2025
The $991 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $28.18 · 2021: $546 · 2022: $368 · 2023: $611 · 2024: $386 · 2025: $991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,988.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $824.90 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $784.87 | 2019-2024 | Acuvue |
| Coopervision INC. | $564.49 | 2019-2025 | Myday Contact Lens, Paragon Crt, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $272.84 | 2022-2025 | Infuse, Biotrue One Day, Xiidra |
| Biotissue Holdings INC. | $265.95 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $112.24 | 2020-2021 | |
| Astellas Pharma US INC | $48.54 | 2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $45.63 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $45.52 | 2025 | Xdemvy |
| Thea Pharma INC. | $37.07 | 2025 | Iyuzeh |
| Baxter Healthcare | $35.59 | 2022 | |
| Dompe US, INC. | $31.27 | 2025 | Oxervate |
| Synergeyes, INC. | $21.74 | 2019 | |
| Abbvie INC. | $21.50 | 2022 | |
| Allergan, INC. | $20.16 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $15.18 | 2024 | Ryzumvi, Tyrvaya |
| Visioneering Technologies, INC. | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lundeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.